Atuss Ds Tannate Suspension
NDC Package 59702-800-15

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Atuss Ds Tannate Suspension is atuss® DS Tannate Suspension is indicated for temporary relief of nasal congestion and cough associated with respiratory tract infections and related conditions such as sinusitis, pharyngitis, bronchitis and asthma when these conditions are complicated by tenacious mucus and/or mucous plugs and congestion. Marketed by Atley Pharmaceuticals, Inc., this product is identified by NDC 59702-800.

Identification & Billing

NDC Package Code
59702-800-15
Package Description
15 mL in 1 BOTTLE
Product Code
59702-800
11-Digit Billing Format
59702080015
RxNorm Crosswalk
  • RxCUI: 668752 - chlorpheniramine maleate 0.8 MG/ML / dextromethorphan hydrobromide 6 MG/ML / pseudoephedrine hydrochloride 6 MG/ML Extended Release Suspension
  • RxCUI: 668752 - chlorpheniramine maleate 4 MG / dextromethorphan HBr 30 MG / pseudoephedrine HCl 30 MG per 5 ML Extended Release Suspension
  • RxCUI: 668995 - chlorpheniramine maleate 0.8 MG/ML / dextromethorphan hydrobromide 6 MG/ML / pseudoephedrine hydrochloride 6 MG/ML Extended Release Suspension [Atuss DS]
  • RxCUI: 668995 - Atuss DS (chlorpheniramine maleate 4 MG / dextromethorphan HBr 30 MG / pseudoephedrine HCl 30 MG) per 5 ML Extended Release Suspension

Clinical Specifications

Proprietary Name
Atuss Ds Tannate Suspension
Dosage Form
-
Usage Information
Atuss® DS Tannate Suspension is indicated for temporary relief of nasal congestion and cough associated with respiratory tract infections and related conditions such as sinusitis, pharyngitis, bronchitis and asthma when these conditions are complicated by tenacious mucus and/or mucous plugs and congestion. Atuss® DS Tannate Suspension is effective in a productive as well as a nonproductive cough, but is of particular value in a dry nonproductive cough which tends to injure the mucous membrane of the air passages.

Regulatory & Marketing

Labeler Name
Atley Pharmaceuticals, Inc.
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
11-21-2006
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (59702-800). Click a package code to view its specific billing and regulatory data.

59702-800-16
473 mL in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 59702-800-15 identifies a specific commercial package of 15 ml in 1 bottle of Atuss Ds Tannate Suspension, labeled by Atley Pharmaceuticals, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Atley Pharmaceuticals, Inc. on November 21, 2006. The current certification is valid through December 31, 2017.

How is this Atley Pharmaceuticals, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 59702080015. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
59702-800-15
11-Digit CMS (5-4-2)
59702-0800-15

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.